Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116842) titled 'How Cannabidiol Affects Tacrolimus Levels in Kidney Transplant Recipients' on Sept. 1.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Coin toss, Lottery, toss of dice, shuffling cards etc Method of allocation concealment:An Open list of random numbers Blinding and masking:Not Applicable
Primary Sponsor: Dr Smita Pattanaik
Condition:
Health Condition 1: N19- Unspecified kidney failure
Intervention:
Intervention1: Cannabidiol (CBD): Cannabidiol will be administered orally at a dose of 5 milligrams per kilogram body weight twice daily for 10 days ...